A strategic partnership to propel health innovation in Québec
The Armand‑Frappier Foundation and the Quebec Center for Innovation in Biotechnology (CQIB) are joining forces to support the advancement of health for all Quebecers. This collaboration marks an important milestone for Québec’s life sciences ecosystem.
True to its mission of preserving Dr. Armand Frappier’s legacy, the Foundation will now also invest in innovation, scientific entrepreneurship, and the development of the next generation of life sciences companies. By partnering with the CQIB, Canada’s first biotechnology incubator, the Foundation strengthens its commitment to research, public health, and the creation of concrete solutions for society.
Supporting the next Generation of scientists and emerging companies
The CQIB, recognized for its key role in the creation and growth of innovative companies for the past 30 years, is a pillar of Laval’s Biotech City. Thanks to this partnership, young entrepreneurs in the health sciences sector will gain access to a new strategic lever: the CQIB Fund of the Armand‑Frappier Foundation, dedicated to supporting their development, commercialization, and international reach.
Concrete benefits for Québec
By contributing to the CQIB Fund, donors will see their philanthropic actions transformed into tangible impacts:
- Creation of Québec-based life sciences companies
- Development of highly specialized jobs
- Intellectual property owned by local companies
- Innovations with a direct effect on Québec’s health, economy, and society
This partnership opens a new chapter where philanthropy, research, and entrepreneurship come together to build a future where innovation and collective well‑being go hand in hand.
To propel health innovation